FDA Broadens Existing Emergency Use of Lilly and Incyte ' s Baricitinib in Patients Hospitalized with COVID-19 Requiring Oxygen

INDIANAPOLIS, July 29, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ:INCY) announced today the U.S. Food and Drug Administration (FDA) has broadened the Emergency Use Authorization (EUA) for baricitinib to...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials